CEO and President
Michael Garippa is the former CEO and President of TandemHeart. He was recruited by TandemHeart in 2002 as a turnaround expert and stayed on as CEO and President. He took TandemHeart from an R&D firm that had lost an aggregate of $50 million and had no commercial sales to a successful company with over $6 million in net income in the 24 months prior to joining SynCardia.
Prior to joining TandemHeart, Mr. Garippa served as CEO and President of Gateway Home Care. In addition, Mr. Garippa was Founder and CEO of Millennium HomeCare and The Prompt Care Companies. His background also includes being National Sales Manager at Omni Medical and Senior Analyst with the NYC Health and Hospitals Corporation. Mr. Garippa holds a B.A. degree from Rutgers University and a master's degree from New York University.
Chief Development Officer
Douglas Nutter joined SynCardia in March 2012. He has 20+ years of experience in materials, operations and management with GE Plastics. As President of Exatec, LLC, he led the formation, negotiation and start-up of a joint venture between GE and Bayer for lightweight, life-saving polycarbonate automotive windows. Mr. Nutter also has 10 years of experience in optics-based medical devices as Vice President of Business Development at Optical Research Associates, and General Manager of Electro-Optics at Zygo Corporation. He received an S.B. in Physics from MIT and began his career as a materials physicist for Hercules.
Chief Financial Officer
Dan Hudspeth brings to SynCardia Systems, Inc. significant United States and international expertise in driving shareholder value with over 20 years of experience in business, finance and market development for private and public companies. Throughout his career, Dan gained significant experience in financing, accounting, manufacturing and distribution, focusing on high-growth private equity-backed and public companies. He has led three public offerings and over 30 private equity and debt financings totaling more than $600 million of capital formation. He was instrumental in five M&A transactions and exits representing over $400 million in shareholder value.
Dan began his career at Deloitte Haskins & Sells. He served as the chief financial officer at Genomica Corp., Rally Development Corp. and Allos Therapeutics. Prior to joining SynCardia, he provided interim executive and board advisory services to several venture capital and private equity-backed companies as a sole proprietor, Cohesive Strategy, LLC. Dan received a B.S. degree in administration with an emphasis in accounting from Colorado State University. He is a certified public accountant – inactive.
NEXT ›› Board of Directors